Loading...

Garraway, Isla P

Title(s)Associate Professor, Urology
Phone64890
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    B ELEMENT IN TATA LESS PROMOTERS
    NIH/NHGRI F31HG000117Apr 1, 1994
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Parikh NR, Huiza C, Patel JS, Tsai S, Kalpage N, Thein M, Pitcher S, Lee SP, Inouye WS, Jordan ML, Sanati H, Jafari L, Bennett CJ, Gin GE, Kishan AU, Reiter RE, Lewis M, Sadeghi A, Aronson WJ, Garraway IP, Rettig MB, Nickols NG. Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease. BMC Cancer. 2019 Apr 01; 19(1):291. PMID: 30935383.
      View in: PubMed
    2. Brennen WN, Zhang B, Kulac I, Kisteman LN, Antony L, Wang H, Meeker AK, De Marzo AM, Garraway IP, Denmeade SR, Isaacs JT. Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate. Oncotarget. 2017 Jul 18; 8(29):46710-46727. PMID: 28493842.
      View in: PubMed
    3. Miller ET, Chamie K, Kwan L, Lewis MS, Knudsen BS, Garraway IP. Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. Cancer Med. 2017 01; 6(1):163-172. PMID: 27997745.
      View in: PubMed
    4. Liu S, Cadaneanu RM, Zhang B, Huo L, Lai K, Li X, Galet C, Grogan TR, Elashoff D, Freedland SJ, Rettig M, Aronson WJ, Knudsen BS, Lewis MS, Garraway IP. Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone. PLoS One. 2016; 11(10):e0163232. PMID: 27711225.
      View in: PubMed
    5. Miyahira AK, Lang JM, Den RB, Garraway IP, Lotan TL, Ross AE, Stoyanova T, Cho SY, Simons JW, Pienta KJ, Soule HR. Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. Prostate. 2016 Feb; 76(2):125-39. PMID: 26477609.
      View in: PubMed
    6. Liu H, Cadaneanu RM, Lai K, Zhang B, Huo L, An DS, Li X, Lewis MS, Garraway IP. Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations. Prostate. 2015 May; 75(7):764-76. PMID: 25663004.
      View in: PubMed
    7. Garraway IP. Targeting the RANKL pathway: putting the brakes on prostate cancer progression in bone. J Clin Oncol. 2013 Oct 20; 31(30):3838-40. PMID: 24043735.
      View in: PubMed
    8. Peek EM, Li DR, Zhang H, Kim HP, Zhang B, Garraway IP, Chin AI. Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. Am J Cancer Res. 2012; 2(6):745-51. PMID: 23226620.
      View in: PubMed
    9. Jiao J, Hindoyan A, Wang S, Tran LM, Goldstein AS, Lawson D, Chen D, Li Y, Guo C, Zhang B, Fazli L, Gleave M, Witte ON, Garraway IP, Wu H. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLoS One. 2012; 7(8):e42564. PMID: 22880034.
      View in: PubMed
    10. Garraway IP. Will identification of a prostate cancer stem cell lead to its cure? Urol Oncol. 2012 Jul-Aug; 30(4):351-2. PMID: 22930822.
      View in: PubMed
    11. Guo C, Liu H, Zhang BH, Cadaneanu RM, Mayle AM, Garraway IP. Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. PLoS One. 2012; 7(4):e34219. PMID: 22514625.
      View in: PubMed
    12. Guo C, Zhang B, Garraway IP. Isolation and characterization of human prostate stem/progenitor cells. Methods Mol Biol. 2012; 879:315-26. PMID: 22610567.
      View in: PubMed
    13. Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S, Plaisier S, Garraway IP, Huang J, Graeber TG, Wu H. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell. 2011 Jun 14; 19(6):792-804. PMID: 21620777.
      View in: PubMed
    14. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science. 2010 Jul 30; 329(5991):568-71. PMID: 20671189.
      View in: PubMed
    15. Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I, Wong SG, Belldegrun AS, Pantuck AJ. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol. 2010 Jun; 183(6):2403-8. PMID: 20403620.
      View in: PubMed
    16. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate. 2010 Apr 01; 70(5):491-501. PMID: 19938015.
      View in: PubMed
    17. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A. 2008 Dec 30; 105(52):20882-7. PMID: 19088204.
      View in: PubMed
    18. Garraway IP, Seligson D, Said J, Horvath S, Reiter RE. Trefoil factor 3 is overexpressed in human prostate cancer. Prostate. 2004 Nov 01; 61(3):209-14. PMID: 15368472.
      View in: PubMed